Get started
Work

Abstract LB-053: Monitoring rearrangement of EML4-ALK in blood platelets predicts outcome to crizotinib treatment in non-small-cell lung cancer patients

Year: 2015
Type: conference-abstract
DOI: 10.1158/1538-7445.am2015-lb-053
Authors: Jonas A. Nilsson, Niki Karachaliou, Pepijn Schellen, Ana Gimenez-Capitan, Jordi Berenguer, Cristina Teixido, Justine L. Kuiper, Esther Drees, Magda Grabowska, Marte van Keulen, Jihane M. Tannous, Danielle A.M. Heideman, Erik Thunnissen, Anne-Marie C. Dingemans, Santiago Viteri, Bakhos A. Tannous, Ana Drozdowskyj, Rafael Rosell, Egbert F. Smit, Thomas Wurdinger
Institutions: Instituto Oncológico Dr. Rosell, Hospital Universitario Dexeus, Amsterdam UMC Location Vrije Universiteit Amsterdam, Massachusetts General Hospital, Maastricht University Medical Centre, Pivotal (Spain)
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W2340576049
Cites:
Cited by:
Related to: 10